75% Spinal Cord Injury Recovery?? Deep Dive in Brazil’s Polylaminine Breakthrough

Описание: The "Bridge" to recovery is in Brazil. 🧬

In a great update for the SCI community as of January 5th, 2026, Brazil’s regulatory agency (ANVISA) has officially green-lit Phase 1 clinical trials for Polylaminin. This isn't a stem cell therapy—it’s a bio-scaffold "mesh" developed at the Federal University of Rio de Janeiro (UFRJ) that acts as a highway for nerves to regrow across the injury gap.

Here is a timeline with chapters for your YouTube video:

00:00 Intro: The Brazilian Breakthrough
01:25 What is Polylaminin? (The Science)
02:44 How It Works: Bridging the Gap
03:35 Dual Mechanism: The Bridge & The Peacekeeper
04:56 Human Trial Results: Did People Walk?
06:10 Hope for Chronic Injuries (The Dog Study)
07:13 Current Status: January 2026 Update
07:35 Next Steps & Future Outlook
08:11 Conclusion: The Research Snowball

Key Highlights:

Unprecedented Data: 75% of ACUTE "complete" (AIS A) patients in a pilot study recovered voluntary motor function within a year.

Real Results: The case of Bruno, a C4 quadriplegic who went from zero movement to walking with a walker.

What's Next: Phase 1 trials start in February focusing on acute thoracic injuries, with combination therapies for chronic scars on the horizon.

This is a turning point in regenerative medicine. I’m doing a massive deep dive into the 25 years of work behind this Brazilian breakthrough on the main channel.

Subscribe to Beyond Paralysis and hit the bell so you don't miss the latest Research. 🔔

Until then, keep well.

#SCI #Paralysis #MedicalBreakthrough #Polylaminin #BeyondParalysis #RegenerativeMedicine #UFRJ